Inhibition of Clostridium perfringens by an Antibiotic Substance Produced by Bacillus licheniformis in the Digestive Tract of Gnotobiotic Mice: Effect on Other Bacteria from the Digestive Tract
AUTOR(ES)
Ducluzeau, R.
RESUMO
A strain of Bacillus licheniformis, established in the digestive tract of gnotobiotic mice, inhibited the subsequent establishment of a Clostridium perfringens strain ingested by the animals. This inhibitory effect depended on the in vivo production by B. licheniformis of an antibiotic substance having a number of the characteristics of bacitracin. If C. perfringens was the first to become established in the digestive tract of the gnotobiotic mice, B. licheniformis also became established but did not produce any antibiotic. Mutants of C. perfringens resistant to the antibiotic substance were not observed when the antibiotic was produced in situ by B. licheniformis, but were rapidly selected when the Bacillus culture filtrate or bacitracin was administered per os. B. licheniformis was also capable of eliminating from the digestive tract 5 of the 13 additional bacterial strains tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429468Documentos Relacionados
- Production of an Antibiotic Substance by Bacillus licheniformis Within the Digestive Tract of Gnotobiotic Mice
- Multiple Antibiotic Resistance Gene Transfer from Animal to Human Enterococci in the Digestive Tract of Gnotobiotic Mice
- Inhibition of Escherichia coli Translocation from the Gastrointestinal Tract by Normal Cecal Flora in Gnotobiotic or Antibiotic-Decontaminated Mice
- Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats.
- Interaction Between Escherichia coli and Shigella flexneri in the Digestive Tract of “Gnotobiotic” Mice
